Pharmafile Logo
Pharmafocus logo
Advanced Search

Pierre Fabre

Showing 8 posts of 8 posts found.

NICE recommends Pierre Fabre’s Nerlynx in adjuvant HER2+ breast cancer

August 7, 2019
Research and Development, Sales and Marketing Cancer, NCIE, NHS, Nerlynx, Pierre Fabre, UK, breast cancer

Pierre Fabre’s Nerlynx (neratinib) has been recommended by NICE as a new option for NHS patients with early hormone-receptor-positive, human …

News
imp_pologne2

Pierre Fabre’s triplet therapy makes strong showing in BRAF V600E-mutant metastatic colorectal cancer

July 8, 2019
Research and Development, Sales and Marketing Cancer, Pierre Fabre, colorectal cancer, pharma

Pierre Fabre chose the European Society for Medical Oncology (ESMO) 21st World Congress on Gastrointestinal Cancer in Barcelona, Spain, to …

News
imp_pologne2

NICE recommends Pierre Fabre’s Braftovi in BRAF V600-mutated advanced melanoma

January 21, 2019
Sales and Marketing Braftovi, Cancer, NICE, Pierre Fabre, UK, melanoma, pharma

Braftovi (encorafenib), a BRAF kinase inhibitor developed by Pierre Fabre, has been awarded approval in combination with Mektovi (binimetinib) by …

News
array_biopharma

Array’s melanoma therapy blasts Roche’s out of water

February 7, 2018
Research and Development Array Biopharma, Pierre Fabre, Roche, biotech, drugs, melanoma, pharma, pharmaceutical

Array Biopharma suffered a serious knock back in early 2017 when its plan to commercialise its drug, binimetinib, were derailed …

News
shutterstock_273326141

Pierre Fabre secures Italian distribution rights for Noventure’s Aprotecol

July 17, 2017
Sales and Marketing Aprotecol, Noventure, Pierre Fabre, biotech, colic, drugs, healthcare, pharma, pharmacuetical

Noventure has allied with Pierre Fabre Pharma Italy in a partnership which will see the latter distribute the Spanish start-up’s …

News

Pierre Fabre loses chief executive

February 11, 2011
Sales and Marketing Olivier Bohuon, Pierre Fabre, Smith & Nephew, appointment, medical devices, sales and marketing

Olivier Bohuon is leaving French pharma company Pierre Fabre after serving just five months as its chief executive. He will …

Appointment

Olivier Bohuon takes post at Pierre Fabre

September 6, 2010
Sales and Marketing Pierre Fabre, appointment, sales and marketing

French pharma company Pierre Fabre has officially appointed Olivier Bohuon to take over from Jean-Pierre Garnier as chief executive. Olivier’s …

Appointment

Olivier Bohuon joins Pierre Fabre

July 16, 2010
Sales and Marketing Abbott, Pierre Fabre, appointment, sales and marketing

Olivier Bohuon is to replace Jean-Pierre Garnier as the head of French pharma company Pierre Fabre from September. Bohuon is …

Appointment

Latest content

Prism BioLab and Ono Pharmaceutical enter joint research and licensing agreement

April 25, 2024

Ascendis Pharma’s Yorvipath approved by MHRA for hypoparathyroidism treatment

April 25, 2024

Eli Lilly acquires new manufacturing facility from Nexus Pharmaceuticals

April 24, 2024

GSK’s Jemperli accepted for FDA review for endometrial cancer treatment

April 24, 2024

Sanofi shares results for phase 3 LUNA 3 trial in immune thrombocytopenia

April 23, 2024